A Study to Quantify Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)
Reduction in Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)
Sponsor: National University Hospital, Singapore
A observational or N/A phase clinical study on Spine Metastasis, this trial is ongoing. The trial is conducted by National University Hospital, Singapore and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Mar 2023 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Mar 2023 [monthly]
Unknown Status
-
Apr 2019 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Apr 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National University Hospital, Singapore
- National University of Singapore
For direct contact, visit the study record on ClinicalTrials.gov .